The incidence of diabetes mellitus in Russia in the trend over 2015–2024

Introduction. In recent years, there has been a marked increase in the incidence of diabetes mellitus (DM) in Russia, which places a heavy burden on the healthcare system.

The purpose: to consider the incidence of DM, including type 1 and type 2, as well as the contribution of active detection methods to the formation of its structure in Russia in the trend over the period from 2015 to 2024.

Materials and methods. Statistical data from form No. 12 and Rosstat on the population for 2015–2024. To analyze the incidence rates of diabetes, including type 1 and type 2, in the trend 2015–2024, dynamic range indicators and the Fisher criterion were used, the differences were significant at < 0.05.

Results. In Russia, the incidence of DM and diabetes type 2 increased markedly in 2015–2024 and reached 310.7 and 292.6 per 100,000 population in 2024. In the structure of the incidence of diabetes, the proportion of diabetes type 2 reached 92.2, and diabetes type 1 — 6.1%. In the structure of newly diagnosed patients with diabetes in 2024, the proportion of patients who were actively identified increased to 31.7% due to an increase in the proportion of patients identified during medical examinations to 27.6%.

Research limitations. Statistical information provides a sufficient sample for the study.

Conclusion. Currently, to analyze the incidence of diabetes in the Russian population, there is a need to develop a new federal statistical observation reporting form containing detailed information on newly diagnosed patients with diabetes.

Compliance with ethical standards. The conclusion of the biomedical ethics committee was not required for this study (the study was based on publicly available official statistics).

Contribution of the authors:
Starodubov V.I. — research concept;
Tsybikova E.B. — research design, text writing, bibliography;
Samoilova Yu.G. — concept and editing;
Kotlovskiy M.Yu. — collection and processing of material.
All co-authors are responsible for approving the final version of the article and ensuring the integrity of all parts of the article.

Funding. The research was not granted any sponsor support.

Conflict of interest. The authors declare no competing interests.

Received: July 7, 2025 / Revised: October 13, 2025 / Accepted: February 19, 2026 / Published: April 30, 2026